Literature DB >> 29050407

Layer chicken embryo survival to hatch when administered an in ovo vaccination of strain F Mycoplasma gallisepticum and locations of bacteria prevalence in the newly hatched chick.

K E C Elliott1, S L Branton2, J D Evans2, P D Gerard3, E D Peebles1.   

Abstract

Mycoplasma gallisepticum (MG) is a bacterial pathogen that causes production losses in layer chickens. To combat MG, multiage layer facilities vaccinate pullets by either spray or eye-drop vaccination. The objective in this study was to evaluate the use of in ovo vaccination as a potential alternative for MG vaccination. Layer embryos at 18 d of incubation were either not-injected (control), or were hand-injected with either commercial Marek's disease vaccine diluent alone or with a high, medium, low, or very low dosage of a live attenuated strain F (FMG) vaccine suspended in the commercial diluent. Hatch success and residual egg embryonic mortality were determined after 23 d of incubation. Six hatched chicks per treatment were swabbed for the detection of FMG at 4 different sites (trachea, mouth and esophagus, yolk sac membrane, and the lumen of the duodenal loop) via real-time PCR. Embryos were found to be administered 106 CFU per dose in the high treatment, 104 CFU/dose in the medium treatment, 102 CFU/dose in the low treatment, and between 5.06 and 5.93 CFU/dose in the very low treatment. Hatch of embryonated eggs was decreased by the medium and high doses (P = 0.02). These embryos died while pipping. No FMG was detected in the control and diluent-injected chicks. In the FMG treatments, FMG was found in all sites and dosages, with a greater number of positive chicks found in the higher FMG dosage treatments. These findings indicate the potential practicality of vaccinating layer embryos with FMG by in ovo injection based on the observed hatch success at lower dosages. Also, once injected into the amnion, the bacteria are present in the upper respiratory and gastrointestinal tracts as well the yolk sac membrane and the small intestine of hatchlings. Future research will need to ascertain the effects of FMG administered by in ovo injection on posthatch immunity and mortality.
© 2017 Poultry Science Association Inc.

Entities:  

Keywords:  Mycoplasma gallisepticum; embryo; in ovo; layer; strain F

Mesh:

Substances:

Year:  2017        PMID: 29050407     DOI: 10.3382/ps/pex196

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


  4 in total

1.  Effects of the In Ovo Vaccination of the ts-11 Strain of Mycoplasma gallisepticum in Layer Embryos and Posthatch Chicks.

Authors:  Abdulmohsen H Alqhtani; Seyed A Fatemi; Katie E C Elliott; Scott L Branton; Jeff D Evans; Spencer A Leigh; Patrick D Gerard; Edgar D Peebles
Journal:  Animals (Basel)       Date:  2022-04-27       Impact factor: 3.231

Review 2.  Vaccines as alternatives to antibiotics for food producing animals. Part 2: new approaches and potential solutions.

Authors:  Karin Hoelzer; Lisa Bielke; Damer P Blake; Eric Cox; Simon M Cutting; Bert Devriendt; Elisabeth Erlacher-Vindel; Evy Goossens; Kemal Karaca; Stephane Lemiere; Martin Metzner; Margot Raicek; Miquel Collell Suriñach; Nora M Wong; Cyril Gay; Filip Van Immerseel
Journal:  Vet Res       Date:  2018-07-31       Impact factor: 3.683

3.  Growth and humoral immune effects of dietary Original XPC in layer pullets challenged with Mycoplasma gallisepticum.

Authors:  K E C Elliott; S L Branton; J D Evans; S A Leigh; E J Kim; H A Olanrewaju; G T Pharr; H O Pavlidis; P D Gerard; E D Peebles
Journal:  Poult Sci       Date:  2020-03-18       Impact factor: 3.352

Review 4.  Current status of vaccine research, development, and challenges of vaccines for Mycoplasma gallisepticum.

Authors:  Muhammad Ishfaq; Wanying Hu; Mohammad Zeb Khan; Ijaz Ahmad; Wenxin Guo; Jichang Li
Journal:  Poult Sci       Date:  2020-06-27       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.